Session Learning Objectives

Those attending this session will receive information that should allow them to:

• Investigate the association between antidepressant use and cognitive decline in patients with dementia;
• Examine the risk of severe dementia, fractures, and death related to antidepressant use;
• Determine the influence of antidepressant class, specific drug, and dosage on cognitive outcomes in dementia patients; and
• Assess the differences in cognitive decline rates among various subgroups, such as sex and baseline cognitive function